Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with anti‐PD‐1 antibody

BACKGROUND: Programmed cell death ligand 1 (PD‐L1) is known to have soluble forms aside from its membrane‐bound forms. The aim of this study was to evaluate the predictive and prognostic values of serum soluble PD‐L1 (sPD‐L1) in patients with non‐small cell lung cancer (NSCLC) who were treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Shuji, Shibaki, Ryota, Matsumoto, Yuji, Yoshida, Tatsuya, Goto, Yasushi, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705908/
https://www.ncbi.nlm.nih.gov/pubmed/33108686
http://dx.doi.org/10.1111/1759-7714.13721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705908/
https://www.ncbi.nlm.nih.gov/pubmed/33108686
http://dx.doi.org/10.1111/1759-7714.13721

Ejemplares similares